Review Article| Volume 2, ISSUE 1, P107-118, May 2022

Sentinel Lymph Node Sampling in Endometrial Cancers

  • Emma C. Rossi
    UNC Division of Gynecologic Oncology, 170 Manning Drive, Physicians Office Building, B105, Chapel Hill, NC 27599.
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina, CB#7572, Physicians Office Building, Chapel Hill, NC 27599, USA
    Search for articles by this author


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Advances in Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Shepherd J.H.
        Revised FIGO staging for gynaecological cancer.
        Br J Obstet Gynaecol. 1989; 96: 889-892
        • Creasman W.T.
        • Morrow C.P.
        • Bundy B.N.
        • et al.
        Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study.
        Cancer. 1987; 60: 2035-2041
        • Walker J.L.
        • Piedmonte M.R.
        • Spirtos N.M.
        • et al.
        Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2.
        J Clin Oncol. 2009; 27: 5331-5336
        • Janda M.
        • Gebski V.
        • Brand A.
        • et al.
        Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial.
        Lancet Oncol. 2010; 11: 772-780
        • Walker J.L.
        • Piedmonte M.R.
        • Spirtos N.M.
        • et al.
        Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study.
        J Clin Oncol. 2012; 30: 695-700
        • Janda M.
        • Gebski V.
        • Davies L.C.
        • et al.
        Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage I endometrial cancer: a randomized clinical trial.
        JAMA. 2017; 317: 1224-1233
        • Kitchener H.
        • Swart A.M.
        • Qian Q.
        • et al.
        Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.
        Lancet. 2009; 373: 125-136
        • Benedetti Panici P.
        • Basile S.
        • Maneschi F.
        • et al.
        Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
        J Natl Cancer Inst. 2008; 100: 1707-1716
        • Randall M.E.
        • Filiaci V.L.
        • Muss H.
        • et al.
        Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
        J Clin Oncol. 2006; 24: 36-44
        • Fleming G.F.
        • Brunetto V.L.
        • Cella D.
        • et al.
        Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
        J Clin Oncol. 2004; 22: 2159-2166
        • Sharma C.
        • Deutsch I.
        • Lewin S.N.
        • et al.
        Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer.
        Am J Obstet Gynecol. 2011; 205: 562 e561-569
        • Nout R.A.
        • Smit V.T.
        • Putter H.
        • et al.
        Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
        Lancet. 2010; 375: 816-823
        • Morton D.L.
        • Thompson J.F.
        • Cochran A.J.
        • et al.
        Sentinel-node biopsy or nodal observation in melanoma.
        N Engl J Med. 2006; 355: 1307-1317
        • Veronesi U.
        • Paganelli G.
        • Viale G.
        • et al.
        A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.
        N Engl J Med. 2003; 349: 546-553
        • Raabe A.
        • Beck J.
        • Gerlach R.
        • et al.
        Near-infrared indocyanine green video angiography: a new method for intraoperative assessment of vascular flow.
        Neurosurgery. 2003; 52 ([discussion: 139]): 132-139
        • Frumovitz M.
        • Plante M.
        • Lee P.S.
        • et al.
        Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial.
        Lancet Oncol. 2018; 19: 1394-1403
        • How J.
        • Gotlieb W.H.
        • Press J.Z.
        • et al.
        Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer.
        Gynecol Oncol. 2015; 137: 436-442
        • Holloway R.W.
        • Bravo R.A.
        • Rakowski J.A.
        • et al.
        Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: a comparison of colorimetric and fluorescence imaging.
        Gynecol Oncol. 2012; 126: 25-29
        • Mariani A.
        • Dowdy S.C.
        • Cliby W.A.
        • et al.
        Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.
        Gynecol Oncol. 2008; 109: 11-18
        • Kern K.A.
        Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
        J Am Coll Surg. 2002; 195: 467-475
        • Martinelli F.
        • Ditto A.
        • Signorelli M.
        • et al.
        Sentinel node mapping in endometrial cancer following hysteroscopic injection of tracers: a single center evaluation over 200 cases.
        Gynecol Oncol. 2017; 146: 525-530
        • Ruiz R.
        • Gorostidi M.
        • Jaunarena I.
        • et al.
        Sentinel node biopsy in endometrial cancer with dual cervical and fundal indocyanine green injection.
        Int J Gynecol Cancer. 2018; 28: 139-144
        • Rossi E.C.
        • Jackson A.
        • Ivanova A.
        • et al.
        Detection of sentinel nodes for endometrial cancer with robotic assisted fluorescence imaging: cervical versus hysteroscopic injection.
        Int J Gynecol Cancer. 2013; 23: 1704-1711
        • Bodurtha Smith A.J.
        • Fader A.N.
        • Tanner E.J.
        Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis.
        Am J Obstet Gynecol. 2017; 216: 459-476.e410
        • Rossi E.C.
        • Kowalski L.D.
        • Scalici J.
        • et al.
        A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
        Lancet Oncol. 2017; 18: 384-392
        • Cusimano M.C.
        • Vicus D.
        • Pulman K.
        • et al.
        Assessment of sentinel lymph node biopsy vs lymphadenectomy for intermediate- and high-grade endometrial cancer staging.
        JAMA Surg. 2021; 156: 157-164
        • Persson J.
        • Salehi S.
        • Bollino M.
        • et al.
        Pelvic sentinel lymph node detection in high-risk endometrial cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging.
        Eur J Cancer. 2019; 116: 77-85
        • Ballester M.
        • Dubernard G.
        • Lecuru F.
        • et al.
        Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).
        Lancet Oncol. 2011; 12: 469-476
        • Barlin J.N.
        • Khoury-Collado F.
        • Kim C.H.
        • et al.
        The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes.
        Gynecol Oncol. 2012; 125: 531-535
        • Tanner E.J.
        • Sinno A.K.
        • Stone R.L.
        • et al.
        Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer.
        Gynecol Oncol. 2015; 138: 542-547
        • Sozzi G.
        • Fanfani F.
        • Berretta R.
        • et al.
        Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study - a multicentric analysis of predictors of failed mapping.
        Int J Gynecol Cancer. 2020; 30: 1713-1718
        • Stephens A.J.
        • Kennard J.A.
        • Fitzsimmons C.K.
        • et al.
        Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure.
        Int J Gynecol Cancer. 2020; 30: 305-310
        • Body N.
        • Gregoire J.
        • Renaud M.C.
        • et al.
        Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer.
        Gynecol Oncol. 2018; 150: 267-273
        • Tucker K.
        • Staley S.A.
        • Gehrig P.A.
        • et al.
        Defining the learning curve for successful staging with sentinel lymph node biopsy for endometrial cancer among surgeons at an academic institution.
        Int J Gynecol Cancer. 2020; 30: 346-351
        • Holloway R.W.
        • Abu-Rustum N.R.
        • Backes F.J.
        • et al.
        Sentinel lymph node mapping and staging in endometrial cancer: a Society of Gynecologic Oncology literature review with consensus recommendations.
        Gynecol Oncol. 2017; 146: 405-415
        • Moloney K.
        • Janda M.
        • Frumovitz M.
        • et al.
        Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer.
        Int J Gynecol Cancer. 2021; 31: 647-655
        • Tanner E.
        • Puechl A.
        • Levinson K.
        • et al.
        Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer.
        Gynecol Oncol. 2017; 147: 535-540
        • Milam M.R.
        • Java J.
        • Walker J.L.
        • et al.
        Nodal metastasis risk in endometrioid endometrial cancer.
        Obstet Gynecol. 2012; 119: 286-292
        • Bogani G.
        • Murgia F.
        • Ditto A.
        • et al.
        Sentinel node mapping vs. lymphadenectomy in endometrial cancer: a systematic review and meta-analysis.
        Gynecol Oncol. 2019; 153: 676-683
        • Ignatov A.
        • Papathemelis T.
        • Ivros S.
        • et al.
        Comparison of survival of patients with endometrial cancer undergoing sentinel node biopsy alone or systematic lymphadenectomy.
        Arch Gynecol Obstet. 2020; 302: 995-1000
        • How J.
        • Gauthier C.
        • Abitbol J.
        • et al.
        Impact of sentinel lymph node mapping on recurrence patterns in endometrial cancer.
        Gynecol Oncol. 2017; 144: 503-509
        • Schlappe B.A.
        • Weaver A.L.
        • Ducie J.A.
        • et al.
        Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: a sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.
        Gynecol Oncol. 2018; 151: 235-242
        • Multinu F.
        • Ducie J.A.
        • Eriksson A.G.Z.
        • et al.
        Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: comparison of comprehensive surgical staging and sentinel lymph node algorithm.
        Gynecol Oncol. 2019; 155: 177-185
        • Guan J.
        • Xue Y.
        • Zang R.Y.
        • et al.
        Sentinel lymph node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk endometrial cancer confined to the uterus before surgery: trial protocol for a non-inferiority randomized controlled trial (SNEC trial).
        J Gynecol Oncol. 2021; 32: e60
        • Marchocki Z.
        • Cusimano M.C.
        • Clarfield L.
        • et al.
        Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics.
        Am J Obstet Gynecol. 2021; 225: 367.e1-367.e9
        • Schiavone M.B.
        • Zivanovic O.
        • Zhou Q.
        • et al.
        Survival of patients with uterine carcinosarcoma undergoing sentinel lymph node mapping.
        Ann Surg Oncol. 2016; 23: 196-202
        • Schlappe B.A.
        • Weaver A.L.
        • McGree M.E.
        • et al.
        Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.
        Gynecol Oncol. 2020; 156: 62-69
        • Edge S.B.B.D.
        • Compton C.C.
        AJCC cancer staging manual.
        7th edition. Springer, New York2010
        • Kim C.H.
        • Khoury-Collado F.
        • Barber E.L.
        • et al.
        Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion.
        Gynecol Oncol. 2013; 131: 714-719
        • St Clair C.M.
        • Eriksson A.G.
        • Ducie J.A.
        • et al.
        Low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma.
        Ann Surg Oncol. 2016; 23: 1653-1659
        • Backes F.J.
        • Felix A.S.
        • Plante M.
        • et al.
        Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: to treat or not to treat?.
        Gynecol Oncol. 2021; 161: 347-352
        • Touhami O.
        • Trinh X.B.
        • Gregoire J.
        • et al.
        Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph node (SLN) metastasis in endometrial cancer.
        Gynecol Oncol. 2015; 138: 41-45
        • Backes F.J.
        • Cohen D.
        • Salani R.
        • et al.
        Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
        Gynecol Oncol. 2019; 153: 496-499
        • Lyman G.H.
        • Giuliano A.E.
        • Somerfield M.R.
        • et al.
        American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
        J Clin Oncol. 2005; 23: 7703-7720
        • Pernas S.
        • Gil M.
        • Benitez A.
        • et al.
        Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence.
        Ann Surg Oncol. 2010; 17: 772-777
        • Giuliano A.E.
        • Hawes D.
        • Ballman K.V.
        • et al.
        Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer.
        JAMA. 2011; 306: 385-393
        • Oonk M.H.M.
        • Slomovitz B.
        • Baldwin P.J.W.
        • et al.
        Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II.
        J Clin Oncol. 2021; 39: 3623-3632
        • Zahl Eriksson A.G.
        • Ducie J.
        • Ali N.
        • et al.
        Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
        Gynecol Oncol. 2016; 140: 394-399
        • Cancer Genome Atlas Research N.
        • Kandoth C.
        • Schultz N.
        • et al.
        Integrated genomic characterization of endometrial carcinoma.
        Nature. 2013; 497: 67-73
        • Leon-Castillo A.
        • de Boer S.M.
        • Powell M.E.
        • et al.
        Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy.
        J Clin Oncol. 2020; 38: 3388-3397
        • Carlson J.W.
        • Kauderer J.
        • Hutson A.
        • et al.
        GOG 244-the lymphedema and gynecologic cancer (LEG) study: incidence and risk factors in newly diagnosed patients.
        Gynecol Oncol. 2020; 156: 467-474
        • Leitao Jr., M.M.
        • Zhou Q.C.
        • Gomez-Hidalgo N.R.
        • et al.
        Patient-reported outcomes after surgery for endometrial carcinoma: prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy.
        Gynecol Oncol. 2020; 156: 147-153
        • Polan R.M.
        • Rossi E.C.
        • Barber E.L.
        Extent of lymphadenectomy and postoperative major complications among women with endometrial cancer treated with minimally invasive surgery.
        Am J Obstet Gynecol. 2019; 220: 263.e261-263.e268
        • Suidan R.S.
        • Sun C.C.
        • Cantor S.B.
        • et al.
        Three lymphadenectomy strategies in low-risk endometrial carcinoma: a cost-effectiveness analysis.
        Obstet Gynecol. 2018; 132: 52-58
        • Nagar H.
        • Wietek N.
        • Goodall R.J.
        • et al.
        Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.
        Cochrane Database Syst Rev. 2021; 6: CD013021